Monthly Archives March 2017

Yes there is major change coming up that we all need to be aware of and manage our stocks accordingly. Effective from 1 June 2017 Celecoxib Pfizer Capsules 100 mg and 200mg will be listed and fully funded in the Pharmaceutical Schedule, replacing Celebrex in the New Zealand market. The current ex-manufacturer price of: - Celebrex Caps 100 mg 60…

Current product being supplied is Loxalate Tab 10 mg 28 (Mylan) via AirFlow. Click here to read latest PHARMAC notification. Please note that until further stock has arrived and the supply issue is resolved ProPharma and PWR have implemented an allocation of 10 x 28 per week. If you have concerns please contact your local Branch Manager or Key Accounts…

Following the goods news relating to previous allocations and the removal of those, the news went from Good News to Okay News. We are currently processing new orders on AFT for stock to ensure we have sufficient to meet market needs. After initially being advised that both brands were available, we have now been advised that we will be receiving…

Dear Wholesalers Please see below the latest update regarding the availability of GSK products: Fortum 1g x 1 is out of stock – order from HCL – Mylan Ceftazidime 1g x 5 If you would like further information or clarification on any of the detail provided please do not hesitate contact myself or Quincy Liu (ph: 021 245 4918).  

From 1 April 2017 there will be a change in the way in which patients using these products will access supplies. Pharmacy will benefit as supplies will be via the patients nearest pharmacy. Click here to read the notification from Roche Diagnostics.

Close